What's new

Orphan designation: Sirolimus Treatment of familial adenomatous polyposis (FAP), 16/04/2025 Positive

Orphan designation: Sirolimus Treatment of familial adenomatous polyposis (FAP), 16/04/2025 Positive

Jun 10, 2025 - 07:05
 0
Orphan designation: Sirolimus Treatment of familial adenomatous polyposis (FAP), 16/04/2025 Positive
Orphan designation: Sirolimus Treatment of familial adenomatous polyposis (FAP), 16/04/2025 Positive
Read More

Tags:

Previous Article

Rhode Features Actor Harris Dickinson in Glazing Mist Campaign

Next Article

Orphan designation: Parahydroxybenzoic acid Treatment of primary ubiquinone defi...

Related Posts

Human medicines European public assessment report (EPAR): Advate, octocog alfa, Date of authorisation: 02/03/2004, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Atazanavir Krka, atazanavir, Date of authorisation: 25/03/2019, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 3, 2025  0

Human medicines European public assessment report (EPAR): Winlevi, clascoterone, Status: Opinion under re-examination

Human medicines European public assessment report (EPAR...

May 15, 2025  0